Physician profile
Hannah DO
NPI 1720582356
$3,087.51
in general payments reported to CMS, 2019-2025
38 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2021: $398 · 2022: $310 · 2023: $1,253 · 2024: $564 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,270.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $369.88 | 2022-2023 | Mako |
| Novo Nordisk INC | $305.73 | 2019-2024 | Ozempic, Rybelsus |
| Medtronic, INC. | $272.59 | 2023-2024 | Intellis Adaptivestim, Ligasure |
| Cranial Technologies, INC | $236.11 | 2022-2025 | Doc Band |
| Glaxosmithkline, LLC. | $189.31 | 2023-2025 | Arexvy, Bexsero, Trelegy Ellipta |
| Abbvie INC. | $150.88 | 2023-2024 | Ubrelvy, Qulipta |
| Axsome Therapeutics, INC. | $124.72 | 2023 | Auvelity |
| Gilead Sciences, INC. | $123.68 | 2023 | Vemlidy |
| E.R. Squibb & Sons, L.L.C. | $116.10 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $101.76 | 2021 | |
| Smith+Nephew, INC. | $96.25 | 2025 | Renasys Touch, Collagenase Santyl, Regranex |
| Corium, LLC | $89.78 | 2023-2024 | Azstarys |
| Organogenesis INC. | $82.62 | 2025 | Affinity, Apligraf |
| Abbott Laboratories | $75.65 | 2023-2024 | Proclaim, Freestyle Libre 3 |
| Medline Industries Lp | $68.31 | 2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $63.77 | 2023 | |
| Alk-Abello, INC | $56.30 | 2023 | Ragwitek, Odactra, Grastek |
| Solventum Corporation | $48.63 | 2025 | Activ.A.C., Promogran Prisma, 3m Cavilon |
| Hologic Sales and Service, LLC | $43.40 | 2023 | Aptima |
| Pfizer INC. | $43.26 | 2023-2024 | |
| Irhythm Technologies, INC. | $41.85 | 2022 | |
| Tris Pharma INC | $35.09 | 2022-2023 | Dyanavel Xr |
| Lilly USA, LLC | $32.95 | 2023 | Mounjaro, Trulicity |
| Kerecis Limited | $31.42 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Molnlycke Health Care US, LLC | $31.34 | 2025 | Mepilex Border Sacrum, Mepilex Border Post-Op Ag, Exufiber Ag+ |
| Inspire Medical Systems, INC. | $28.82 | 2023 | Inspire |
| Urgo Medical North America, LLC | $28.13 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Srs Medical Systems, INC. | $24.04 | 2024 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Ironshore Pharmaceuticals INC. | $23.45 | 2024 | |
| Organon LLC | $23.20 | 2021 | |
| Halozyme INC | $19.71 | 2023 | |
| Verrica Pharmaceuticals INC. | $18.43 | 2024 | Ycanth |
| Dexcom, INC. | $18.19 | 2023 | Dexcom G6 Transmitter |
| Sobi, INC | $16.34 | 2021 | |
| Idorsia Pharmaceuticals US INC | $15.28 | 2023 | Quviviq |
| Ferring Pharmaceuticals INC. | $15.18 | 2023 | Rebyota |
| Merck Sharp & Dohme LLC | $13.69 | 2023 | Vaxneuvance, Gardasil 9, Vaxelis |
| Vbi Vaccine (Delaware) INC. | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah DO listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.